Research on COVID-19
Pandemic

The following research projects were rapidly established to explore how COVID-19 impacts people who use drugs (PWUD). The findings will help inform future research and guidance for healthcare professionals, service providers, and policymakers.

Rapid Assessment: Impact of COVID-19 on PWUD in Canada

CRISM is conducting two studies on COVID-19’s impact on people who use drugs (PWUD) to identify areas of most urgent need, make recommendations for improvements to services, and inform strategies for future pandemics. The studies will deliver a rapid assessment report for decision makers and service providers, and will be followed by development of peer-reviewed publications and evaluation activities.

Quantitative Evaluation Using Ongoing Prospective Cohort Studies (300-500 interviews)

A nationally developed COVID-19 survey will be administered to PWUD already enrolled in four ongoing Canadian cohort studies: HepCo, OiSIS-Toronto, VIDUSACCESS and ARYS. These quantitative studies will help to identify and assess the impacts of local harm reduction or health service interventions that are available to PWUD, as the government’s response to the COVID-19 pandemic evolves.

In-Depth Qualitative Interviews

Semi-structured interviews with PWUD across the country have documented a myriad of serious impacts of the COVID-19 pandemic on their health and well-being. This national qualitative research study identified issues PWUD are experiencing during the COVID crisis and have made recommendations to change services to respond to the most urgent needs.

From May to July, 2020, we conducted 200 interviews with people who live in BC, the Prairies, Ontario, Quebec, and the Atlantic provinces. The final report can be found here.

An article documenting the impacts of COVID-19 on substance use and supply, titled Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada can be found here.

Final report (EN)

Topic

Emergency care

decriminalisation

Harm reduction

Law enforcement/incarceration

Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l’usage d’opioïdes vendus sur ordonnance

Bastien G, Abboud A, McAnulty C, Mahroug A, Le Foll B, Socias ME, Juteau LC, Dubreucq S, Jutras-Aswad D., Can J Psychiatry. 2025

Opioid agonist treatment

Prescription monitoring

Recovery

Substance

Alcohol

Cannabis

Injectable drug use

Tobacco/nicotine

Verified by ExactMetrics